🇺🇸 FDA
Patent

US 8247393

Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

granted A61KA61K31/56A61K31/58

Quick answer

US patent 8247393 (Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof) held by TEVA WOMEN'S HEALTH, INC. expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA WOMEN'S HEALTH, INC.
Grant date
Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/56, A61K31/58, A61K47/10, A61K47/14